Sfoglia per Autore
Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
2025 Yang, M; Henderson, A; Talebi, A; Atherton, J; Chiang, C; Chopra, V; Comin-Colet, J; Kosiborod, M; Kerr Saraiva, J; Claggett, B; Desai, A; Kolkhof, P; Viswanathan, P; Lage, A; Lam, C; Senni, M; Shah, S; Rohwedder, K; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Jhund, P; Solomon, S; Mcmurray, J
Time to Significant Benefit of Finerenone in Patients With Heart Failure
2025 Vaduganathan, M; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Mcmurray, J; Solomon, S
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial
2025 Ostrominski, J; Mc Causland, F; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Schloemer, P; Brinker, M; Scheerer, M; Mcmurray, J; Solomon, S; Vaduganathan, M
Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial
2025 Desai, A; Vaduganathan, M; Claggett, B; Kulac, I; Jhund, P; Cunningham, J; Borentain, M; Lay-Flurrie, J; Viswanathan, P; Rohwedder, K; Amarante, F; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Kosiborod, M; Mcmurray, J; Solomon, S
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART Analysis
2025 Ostrominski, J; Filippatos, G; Claggett, B; Miao, Z; Desai, A; Jhund, P; D. Henderson, A; Scheerer, M; Rohwedder, K; Amarante, F; Brinker, M; Lay-Flurrie, J; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Rossing, P; Ruilope, L; Anker, S; Pitt, B; Agarwal, R; Mcmurray, J; Solomon, S; Vaduganathan, M
Ultrasound Assessment of Venous and Pulmonary Congestion in Left Ventricular Assist Devices Patients
2025 Iacovoni, A; Giaccherini, C; Paris, S; Abete, R; Vittori, C; Inciardi, R; Zucchetti, O; Terzi, A; Senni, M
A rare case of cytomegalovirus myocarditis complicating rejection after heart transplantation: Case report and review of literature
2025 Abete, R; Iacovoni, A; Vittori, C; Sebastiani, R; Candiago, E; Gianatti, A; Terzi, A; Senni, M
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trial
2025 Reddy, Y; Butler, J; Anstrom, K; Blaustein, R; Bonaca, M; Corda, S; Ezekowitz, J; Lam, C; Lewis, E; Lindenfeld, J; Mcmullan, C; Mentz, R; O'Connor, C; Patel, M; Ponikowski, P; Rosano, G; Saldarriaga, C; Senni, M; Udelson, J; Voors, A; Zannad, F
Wearable Accelerometer-Derived Measures of Physical Activity in Heart Failure: Insights From the DETERMINE trials
2025 Docherty, K; Buendia Lopez, R; Folkvaljon, F; Boer, R; Chen, J; Hammarstedt, A; Kitzman, D; Kosiborod, M; Langkilde, A; Reicher, B; Senni, M; Wilderäng, U; Verma, S; Cowie, M; Solomon, S; Mcmurray, J
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction The FINEARTS-HF Randomized Clinical Trial
2025 Desai, A; Jhund, P; Vaduganathan, M; Claggett, B; Cunningham, J; Pabon, M; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Amarante, F; Lay-Flurrie, J; Scheerer, M; Lage, A; Mcmurray, J; Solomon, S
ANMCO position paper: Diagnosis and treatment of heart failure with preserved ejection fraction
2025 Iacovoni, A; Navazio, A; De Luca, L; Gori, M; Corda, M; Milli, M; Iacoviello, M; Lenarda, A; Tano, G; Marini, M; Iorio, A; Mortara, A; Mureddu, G; Zilio, F; Chimenti, C; Cipriani, M; Senni, M; Bilato, C; Marco, M; Geraci, G; Pascale, V; Riccio, C; Scicchitano, P; Tizzani, E; Gulizia, M; Nardi, F; Gabrielli, D; Colivicchi, F; Grimaldi, M; Oliva, F
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial
2025 Mc Causland, F; Vaduganathan, M; Claggett, B; Gori, M; Jhund, P; Mcgrath, M; Neuen, B; Packer, M; Pfeffer, M; Rouleau, J; Senni, M; Swedberg, K; Zannad, F; Zile, M; Lefkowitz, M; Mcmurray, J; Solomon, S
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF
2025 Butt, J; Henderson, A; Jhund, P; Claggett, B; Desai, A; Lay-Flurrie, J; Viswanathan, P; Lage, A; Scheerer, M; Lam, C; Senni, M; Shah, S; Voors, A; Bauersachs, J; Fonseca, C; Kosiborod, M; Linssen, G; Petrie, M; Schou, M; Verma, S; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Implementation of guideline-recommended medical therapy for patients with heart failure in Europe
2025 Volterrani, M; Seferovic, P; Savarese, G; Spoletini, I; Imbalzano, E; Bayes-Genis, A; Jankowska, E; Senni, M; Metra, M; Chioncel, O; Coats, A; Rosano, G
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF
2025 Matsumoto, S; Jhund, P; Henderson, A; Bauersachs, J; Claggett, B; Desai, A; Brinker, M; Schloemer, P; Viswanathan, P; Mares, J; Scalise, A; Lam, C; Linssen, G; Kerr Saraiva, J; Senni, M; Troughton, R; Udell, J; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease
2025 Ostrominski, J; Claggett, B; Miao, Z; Filippatos, G; Desai, A; Jhund, P; Henderson, A; Brinker, M; Schloemer, P; Viswanathan, P; Lage, A; Rohwedder, K; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Rossing, P; Ruilope, L; Anker, S; Pitt, B; Agarwal, R; Mcmurray, J; Solomon, S; Vaduganathan, M
Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
2025 Vardeny, O; Vaduganathan, M; Claggett, B; Desai, A; Jhund, P; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Matsumoto, S; Merkely, B; Zieroth, S; Yilmaz, M; Lay-Flurrie, J; Viswanathan, P; Horvat-Broecker, A; Scalise, A; Mcmurray, J; Solomon, S
Economic Evaluation of Patiromer in Patients with Concomitant Heart Failure and Chronic Kidney Disease in Italy
2025 Senni, M; Paoletti, E; Stawowczyk, E; Hale, M; De Arellano, A
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial
2025 Docherty, K; Henderson, A; Jhund, P; Claggett, B; Desai, A; Mueller, K; Viswanathan, P; Scalise, A; Lam, C; Senni, M; Shah, S; Voors, A; Zannad, F; Pitt, B; Vaduganathan, M; Solomon, S; Mcmurray, J
Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: The VELOCITY study
2025 Greene, S; Corda, S; Mcmullan, C; Palombo, G; Schooss, C; Vlajnic, V; Walkamp, K; Senni, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile